FTSE battles with drugs

clock

The FTSE 100 Index fell 23 points, or 0.4%, to 6,208 points today, led by drug companies GlaxoSmithKline and AstraZeneca.

GlaxoSmithKline declined 1.88% to £13.60 and AstraZeneca fell 2.11% to £30.10 on fears the US Congress will cut the price of drugs following Democrats triumph in the recent mid-term elections. The miners presented a mixed picture, as BHP Billiton fell 2.59% to £10.16 and Xstrata dropped 2.51% to £22.95, while Lonmin jumped 3.04% to £31.83 on the back of bid rumours. Anglo American rose 1.22% to £24.96 after the Oppenheimer family sold a third of its stake in the world's second-biggest miner to China Vision Resources. The transaction is worth around £419m. In the US, the Dow Jones indu...

To continue reading this article...

Join Professional Adviser for free

  • Unlimited access to real-time news, industry insights and market intelligence
  • Stay ahead of the curve with spotlights on emerging trends and technologies
  • Receive breaking news stories straight to your inbox in the daily newsletters
  • Make smart business decisions with the latest developments in regulation, investing retirement and protection
  • Members-only access to the editor’s weekly Friday commentary
  • Be the first to hear about our events and awards programmes

Join

 

Already a Professional Adviser member?

Login

More on Investment

Infrastructure: A good investment gone bad – and then good again?

Infrastructure: A good investment gone bad – and then good again?

'Infrastructure - a victim of a unique set of circumstances'

Darius McDermott
clock 02 May 2024 • 5 min read
Investment opportunities 'differ by client age group'

Investment opportunities 'differ by client age group'

‘Advisers should consider personal circumstances when it comes to investment’

Isabel Baxter
clock 02 May 2024 • 1 min read
Future of Investment Festival: Our specialist sessions for advisers

Future of Investment Festival: Our specialist sessions for advisers

Future-proofing advice, building sustainable portfolios, all things SDR

Professional Adviser
clock 02 May 2024 • 2 min read